-
Truist Securities Raises Price Target on Gilead Sciences, Inc. (GILD) to $145, Keeps Buy Rating
01 Feb 2026 19:08 GMT
Gilead Sciences, Inc. (NASDAQ:GILD) is among … Securities Raises Price Target on Gilead Sciences, Inc. (GILD) to $145, Keeps … also provided an update on Gilead Sciences, Inc. (NASDAQ:GILD). The … for the group this year. Gilead Sciences, Inc. (NASDAQ:GILD) is …
-
UBS Turns More Bullish on Gilead Sciences, Inc. (GILD) Amid Positive Pharma Sector Outlook
31 Jan 2026 20:30 GMT
Gilead Sciences, Inc. (NASDAQ:GILD) is among … lifted the price target on Gilead Sciences, Inc. (NASDAQ:GILD) from $145 … also raised its target on Gilead Sciences, Inc. (NASDAQ:GILD) to $150 … the company’s HIV business. Gilead Sciences, Inc. (NASDAQ:GILD) is …
-
<![CDATA[NCCN Names Trodelvy a Preferred First-Line Treatment for Metastatic TNBC]]>
05 Feb 2026 02:06 GMT
… than its currently approved indications. Gilead Sciences has submitted supplemental applications to … in Oncology (NCCN Guidelines®),” by Gilead Sciences. News release; Feb. 4, 2026 …
-
API Manufacturing: Key Trends Reshaping the Global Market
05 Feb 2026 01:41 GMT
… .
In recent months, Sanofi, AstraZeneca, Gilead Sciences, Johnson & Johnson, Takeda, GSK …
-
Don Lemon to Be Honored With Lifetime Achievement Award at Truth Awards
05 Feb 2026 00:29 GMT
… the Torch Awards, powered by Gilead Sciences, on March 20, and followed …
-
GSK’s oncology and HIV drugs drive 7% sales rise in 2025
04 Feb 2026 19:33 GMT
… 2025, Citi analysts expect that Gilead Sciences will continue to be the …
-
As U.S. Life Sciences Market Recovers, “Definite Dichotomy” Among Companies
04 Feb 2026 17:57 GMT
… south in Foster City, CA, Gilead Sciences is building a 182,000 … Diego.
In the Bay Area, Gilead Sciences and [Roche subsidiary] Genentech both …
-
WACO Theater Center Announces Launch of Still Here Magazine, Centering Black Women Impacted by HIV
04 Feb 2026 16:38 GMT
… Vice-President, Corporate Responsibility, Gilead Sciences, Inc.
Editorial Team
… .com/.
About Gilead Sciences: Gilead Sciences, Inc. is a biopharmaceutical … /Twitter (@Gilead Sciences) and LinkedIn (@Gilead-Sciences).
Thursday, February …
-
Medicare Targets Price Cut for Key HIV Drug
04 Feb 2026 14:43 GMT
… . The drug is made by Gilead Sciences. Biktarvy use has surged since …
-
Pharmaceuticals Market to Register a Robust CAGR of 8.19% During the 2026–2034 Forecast Period
04 Feb 2026 13:00 GMT
… .K.)
Amgen Inc. (U.S.)
Gilead Sciences, Inc. (U.S.)
Takeda Pharmaceutical …
About
© 1995-2026